Christopher Klaus

NeuroLaunch is the world’s first accelerator program for neuroscience startups. We apply the methodology of lean early-stage company acceleration, which has risen to global prominence as a model for high-tech startups, to neuroscience. We provide a new pathway to success for neuroscience startups: • Seed funding • Specialized 90-day curriculum • Strategic partnerships • World-class mentor network • Direct introductions to neuro-oriented VCs and angel investors We welcome prospective Mentors, Partners, Sponsors, Investors, and NeuroLaunch Companies. To learn more, visit www.NeuroLaunch.com.

CyberLaunch is the worlds leading accelerator for machine learning and information security startups.

NeuroLaunch is the world’s first accelerator program for neuroscience startups. We apply the methodology of lean early-stage company acceleration, which has risen to global prominence as a model for high-tech startups, to neuroscience. We provide a new pathway to success for neuroscience startups: • Seed funding • Specialized 90-day curriculum • Strategic partnerships • World-class mentor network • Direct introductions to neuro-oriented VCs and angel investors We welcome prospective Mentors, Partners, Sponsors, Investors, and NeuroLaunch Companies. To learn more, visit www.NeuroLaunch.com.

AutoCruitment is a metrics-driven ecosystem of patient recruitment and engagement solutions, digitizing and revolutionizing the end-to-end patient and client experience. Our multifaceted approach utilizes sophisticated algorithms, advanced automation, and over 1,500 direct-to-patient online channels to find, screen, and automatically refer highly qualified patients with a greater chance of randomization success. The results are higher enrollment and greater patient engagement, accelerating timelines and exceeding milestones at every phase of clinical research. The AutoCruitment Difference: •Targeted: The AutoCruitment platform’s proprietary algorithms and innovative approach help precisely target your ideal patient population, reaching over 247 million patients to date •Experienced: AutoCruitment has completed over 578 studies and has a continuously learning and growing database of over 10 million patients •Technology-Enabled: The AutoCruitment platform utilizes advanced online screeners to simultaneously screen for multiple studies and provide customized cohort volumes based on your project’s needs •Volume- and Quality-Focused: The far-reaching power of the AutoCruitment platform and our direct-to-patient methodology excels at attracting and retaining optimal volumes of highly qualified patients •Transparent: The AutoCruitment portal and its robust reporting capabilities enable complete and real-time transparency from the very beginning •Metrics-Driven: Our patient recruitment scientists work in complete collaboration with your study teams and research sites to optimize the program and increase randomization by an average of 97% per month AutoCruitment delivers something different. Our comprehensive ecosystem of scalable solutions offers a 3-day startup time and swiftly removes the recruitment barrier for biotech innovations and pharmaceutical research, shortening timelines and trimming budgets for a quicker, smoother path to market.